Biomerica Historical Income Statement
| BMRA Stock | USD 0.32 0.02 5.88% |
Historical analysis of Biomerica income statement accounts such as Interest Expense of 32.2 K, Selling General Administrative of 5.2 M or Total Revenue of 7.6 M can show how well Biomerica performed in making a profits. Evaluating Biomerica income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Biomerica's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Biomerica latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biomerica is a good buy for the upcoming year.
Biomerica |
About Biomerica Income Statement Analysis
Biomerica Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Biomerica shareholders. The income statement also shows Biomerica investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Biomerica Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Biomerica generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Biomerica minus its cost of goods sold. It is profit before Biomerica operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Biomerica. It is also known as Biomerica overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Biomerica whose combined shares represent less than 50% of the total outstanding shares issued by Biomerica have a minority interest in Biomerica.Most accounts from Biomerica's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Biomerica current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.At present, Biomerica's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 7.6 M, whereas Depreciation And Amortization is forecasted to decline to about 212 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.0M | 446K | 611K | 580.5K | Total Revenue | 18.9M | 5.3M | 5.4M | 7.6M |
Biomerica income statement Correlations
Click cells to compare fundamentals
Biomerica Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biomerica income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 398.6K | 375.9K | 594.8K | 351K | 374K | 212.0K | |
| Interest Expense | 47.0 | 9.0 | 367.0 | 26.6K | 30.6K | 32.2K | |
| Selling General Administrative | 2.3M | 4.6M | 5.7M | 6.1M | 5.5M | 5.2M | |
| Total Revenue | 6.7M | 7.2M | 18.9M | 5.3M | 5.4M | 7.6M | |
| Gross Profit | 1.8M | 497.0K | 3.0M | 446K | 611K | 580.5K | |
| Other Operating Expenses | 9.1M | 13.7M | 23.4M | 12.6M | 11.8M | 8.9M | |
| Operating Income | (2.4M) | (6.5M) | (4.5M) | (7.2M) | (6.4M) | (6.0M) | |
| Ebit | (2.3M) | (7.4M) | (4.5M) | (7.1M) | (6.4M) | (6.0M) | |
| Ebitda | (1.9M) | (7.1M) | (3.9M) | (6.7M) | (6.0M) | (5.7M) | |
| Cost Of Revenue | 4.9M | 6.7M | 15.9M | 4.9M | 4.8M | 5.0M | |
| Total Operating Expenses | 4.2M | 7.0M | 7.5M | 7.7M | 7.0M | 3.9M | |
| Income Before Tax | (2.3M) | (6.5M) | (4.5M) | (7.1M) | (5.9M) | (5.6M) | |
| Total Other Income Expense Net | 71.2K | 66.5K | 26.6K | 134K | 431K | 452.6K | |
| Net Income | (2.3M) | (6.5M) | (4.5M) | (7.1M) | (6.0M) | (5.7M) | |
| Income Tax Expense | 7.4K | 13.1K | 23.7K | 51K | 42K | 44.1K | |
| Research Development | 1.9M | 2.4M | 1.8M | 1.6M | 1.5M | 822.3K | |
| Net Income Applicable To Common Shares | (2.3M) | (6.5M) | (4.5M) | (7.1M) | (6.4M) | (6.1M) | |
| Net Income From Continuing Ops | (2.3M) | (6.5M) | (4.5M) | (7.1M) | (6.0M) | (5.7M) | |
| Tax Provision | 7.4K | 13.1K | 23.7K | 51K | 42K | 46.6K | |
| Interest Income | 71.2K | 66.9K | 26.6K | 133K | 431K | 452.6K | |
| Net Interest Income | 71.2K | 66.5K | 26.6K | 133K | 431K | 452.6K | |
| Reconciled Depreciation | 398.6K | 375.9K | 594.8K | 351K | 374K | 366.2K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.327 | Quarterly Revenue Growth 0.055 | Return On Assets (0.39) | Return On Equity (0.76) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.